<p>Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers.</p>

Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers.

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition

This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.

Share Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition

Sign up to save your podcasts

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition

Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition

More shows like Gynecologic Oncology Update

NEJM This Week

Breast Cancer Update

Lung Cancer Update

Hematologic Oncology Update

Prostate Cancer Update

Gastrointestinal Cancer Update

Dermatologic Oncology Update

Research To Practice | Oncology Videos

Up First from NPR

ASCO Guidelines

The Peter Attia Drive

Listen to Gynecologic Oncology

Oncology Today with Dr Neil Love

SGO on the GO

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions

IJGC conversations

Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing